May 13 (Reuters) - MEI Pharma Inc MEIP.O:
MEI PHARMA REPORTS THIRD QUARTER FISCAL YEAR 2025 CASH POSITION
MEI PHARMA INC: EVALUATION OF STRATEGIC ALTERNATIVES IS ONGOING
Source text: ID:nBw4PgQNFa
Further company coverage: MEIP.O
((Reuters.Briefs@thomsonreuters.com;))